Wednesday February 10 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Gastrointestinal Stromal Tumor GIST News and Headlines
Gastrointestinal Stromal Tumor GIST News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's Gastrointestinal Stromal Tumor GIST
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Gastrointestinal Stromal Tumor GIST
.
Comparison of Two Doses of Imatinib for the Treatment of Unresectable or Metastatic Gastrointestinal Stromal T
Journal of Clinical Oncology:
similar ...
Data Show Progression-Free Survival Advantage With Sutent In Patients With Pancreatic Neuroendocrine Tumors
Pharma Live:
similar ...
Pfizer's new pipeline shows growth and diversity in research and development
News-Medical.Net:
similar ...
Patients with rare cancer get a second chance to fight back
Individual.com:
similar ...
New Data Show Progression-Free Survival Advantage with Sutent (sunitinib) vs Placebo in Patients with Pancreat
PharmiWeb:
similar ...
New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas
FinanzNachrichten.de:
similar ...
Pfizer: Data Show Progression-Free Survival Advantage with Sutent...
Zibb:
similar ...
Early action against rare cancer reduces relapse risk
Pharma Live:
similar ...
Data Show Progression-Free Survival Advantage With Sutent In Patients With Pancreatic Neuroendocrine Tumors
PharmiWeb:
similar ...
Pfizer to seek expanded indication for Sutent for pancreatic cancer
HemOnc Town:
similar ...
Sutent Delays Progression of Pancreatic Neuroendocrine Tumors
Cancer Consultants:
similar ...
Early action against rare cancer reduces relapse risk - Zibb.com
Zibb:
similar ...
Early action against rare cancer reduces relapse risk
Therapeutics Daily:
similar ...
Early action against rare cancer reduces relapse risk
Canada NewsWire:
similar ...
Early action against rare cancer reduces relapse risk
Individual.com:
similar ...
University of Pittsburgh Schools of the Health Sciences: Drug shows promise as new treatment for gut tumor
NewsRX:
similar ...
Data Show Progression-Free Survival Advantage With Sutent(R) In Patients With Pancreatic Neuroendocrine Tumors
Medical News Today:
similar ...
Pfizer's Sutent shows progress-free survival in patients with pancreatic neuroendocrine tumors
Pharma Letter:
similar ...
Pfizer's phase 3 trial of Sutent in pancreatic neuroendocrine tumours shows progression-free survival advantag
PharmaBiz:
similar ...
IPI-504 Fails to Improve Outcomes for Patients With GIST Refractory to TKIs: Presented at ASCO-GI
Doctors Guide:
similar ...
